Gmelinoside I, a New Flavonol Glycoside from Limonium gmelinii

Zhanar A. Kozhamkulova, Mohamed M. Radwan, Galiya E. Zhusupova, Zharylkasyn A. Abilov, Saniya N. Rahadilova, Samir Anis Ross

Natural Product Communications, 2010

Full text Open access: Green Metadata (CSL-JSON)

DOI 10.1177/1934578x1000500715

Data confidence 70 medium

How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Gmelinoside I (1), a new flavonol glycoside, was isolated and chemically characterized as 3,5,7,3',4',5'-hexahydroxy-3-O-alpha-D-galactopyranosylflavone from the aerial part of Limonium gmelinii Kuntze (Plumbaginaceae).. Other compounds were identified as (-)-epigallocatechin-3-O-gallate, myricetin, myricetin-3-O-alpha-L-rhamnopyranoside, myricetin-3-O-beta-D-galactoside-6"-O-gallate and caprolactam. The antibacterial, antifungal and antileishmanial activities of the isolated compounds were evaluated. Myricetin showed moderate antileishmanial activity.